Oncology Firm TransCode Therapeutics Looks To Raise US$25 Million In IPO

Oncology company TransCode Therapeutics, Inc. is set to begin publicly trading its equityon the Nasdaq Capital Market today under the symbol “RNAZ.” The company is looking to raise an aggregate sum of US$25.0 million in its initial public offering.

The offering will consist of 6,250,000 common shares priced at US$4.00 per share. The underwriters were also granted a 45-day over-allotment option to purchase an additional 937,500 common shares at the same offering price, bringing the possible proceeds of the offering to US$28.8 million.

In its statement, TransCode refers to itself as an RNA oncology company centered on the belief that cancer can be addressed through RNA therapeutics. Proceeds from the offering will be intended to progress the trial and develop its therapeutic candidate, TTX-MC138, which is focused on treating metastatic cancer.

The offering is expected to close on July 13, 2021, subject to customary closing conditions. Fordham Financial division ThinkEquity acts as the sole underwriter for the offering.


Information for this briefing was found via Sedar and TransCode. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Goliath Resources Hits 10.60 g/t Gold Over 22.82 Metres, Highest Grade Results In Third Distinct Rock Package At Surebet Discovery

Four Countries Control the Fertilizer That Feeds the World | Sage Potash

$10,000 Gold Is Just A Question of Time | Florian Grummes

Recommended

Antimony Resources Drills 5.27% Sb Over 4.95 Metres In Latest Results

Nord Precious Metals Identifies 29 Veins At Castle East Following 3D Modeling

Related News

Winery Co-founded By Actresses Nina Dobrev, Julianne Hough Fresh Vine Prices US$22 Million IPO

Napa Valley winery Fresh Vine Wine, Inc. (NYSE: VINE) began trading on the New York...

Tuesday, December 14, 2021, 02:16:00 PM

Radiation Oncology Firm Shuttle Pharmaceuticals Prices US$10 Million IPO

Pharmaceutical company focused on radiation therapy treatment Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) started trading...

Thursday, September 1, 2022, 02:21:00 PM

Solar Car Maker Sono Motors Prices US$150 Million IPO

Electric solar car manufacturer Sono Motors (Nasdaq: SEV) started publicly trading on the Nasdaq Global...

Wednesday, November 17, 2021, 03:34:00 PM

Crypto Firm Argo Blockchain Prices US$112.5 Million IPO

Cryptocurrency mining company Argo Blockchain Plc (Nasdaq: ARBK) started trading on the Nasdaq Global Select...

Thursday, September 23, 2021, 03:48:00 PM

Real Estate-Focused Fintech SPAC Southport Acquisition Prices US$200 Million IPO

Special purpose acquisition company Southport Acquisition Corporation (NYSE: PORT.U) went public on Friday at the...

Monday, December 13, 2021, 02:19:00 PM